Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long LLY ETF

29.17
+0.16500.57%
Volume:66.21K
Turnover:1.94M
Market Cap:45.94M
PE:- -
High:29.60
Open:29.05
Low:28.83
Close:29.01
52wk High:31.19
52wk Low:12.18
Shares:1.57M
Float Shares:1.57M
Volume Ratio:1.00
T/O Rate:4.20%
Dividend:0.70
Dividend Rate:2.42%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
32 mins ago

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
39 mins ago

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
2 hours ago

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
7 hours ago

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

TIPRANKS
·
19 hours ago

Sector Update: Healthcare

MT Newswires Live
·
21 hours ago

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

TIPRANKS
·
22 hours ago

Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation

Simply Wall St.
·
Yesterday

Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance

Reuters
·
Yesterday

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
Yesterday

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
Yesterday

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Yesterday

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Yesterday

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20